Application of retin-1 in treatment of septicopyemia

• Main Authors: TAO MEIHUI, YAN WEI, FU YU
• Format: Patent
• Language: Chinese; English
• Published: 08.12.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention belongs to the technical field of biological medicines, and particularly discloses application of retin-1 in treatment of septicopyemia. The invention relates to application of retin-1 in preparation of drugs for treating septicopyemia diseases. The invention discloses application of retin-1 in preparation of a product for diagnosing septicopyemia. The retin-1 can effectively inhibit development of septicopyemia and complications of septicopyemia, so that septicopyemia and complications of septicopyemia are relieved, and the retin-1 has a treatment effect. The omentin-1 can also be used as a detection target for detecting the development of the septicopyemia, the development of the septicopyemia is monitored by detecting the expression condition of the omentin-1, and particularly, the possibility of the development of the septicopyemia is prompted when the omentin-1 is abnormally reduced. 本发明属于生物医药技术领域，具体公开网膜素-1在治疗脓毒血症中的用途。网膜素-1在制备治疗脓毒血症疾病的药物中的应用。网膜素-1在制备诊断脓毒血症产品中的应用。本发明中网膜素-1能够有效的抑制脓毒血症及其并发症的发展